Christopher Woods has been studying emerging infections for his entire career, but hasn't seen anything quite like this.
Watch a recorded webinar featuring Duke School of Medicine experts, including faculty member Chris Woods, discussing the public health impact of the corona virus and Duke’s research related to COVID-19 and infectious diseases.
Last year, Ryanne Wu returned from a three year stay in Singapore where she took the opportunity to implement the MeTree platform through a large epidemiological study of whole genome sequencing.
After many years of service and dedication, Tim Veldman, director of center strategy and operations, is leaving CAGPM to embark on the next phase in his career.
P. Kelly Marcom and Dorothy Sipkins launched a proof-of-concept clinical trial of a new drug for hormone receptor positive breast cancer patients whose disease has spread to the bone.
Co-led by Geoff Ginsburg, the Smart Toilet Bass Connections team has been hard at work developing prototypes of a "Smart Toilet," which would enable the hands-free collection of waste that can be used for early disease detection and to test and monitor for infectious diseases.
Lori Orlando, along with a team at Vanderbilt, was awarded a NIH Moonshot grant focused on boosting hereditary cancer identification. The team will use MeTree to collect and analyze family health history.
The Enabling Precision Health and Medicine Bass Connections team, led by Susanne Haga has been renewed for the 2019-2020 school year.
A new Bass Connections project, the Smart Toilet: A disruptive technology to improve health and wellness, led by Geoff Ginsburg, has been funded for the 2019-2020 school year.
Ephraim Tsalik is one of five finalists for the Antimicrobial Resistance Diagnostic Challenge through NIH. He will receive a grant to further develop his prototype and supply it for testing to two CLIA-certified independent laboratories.
CAGPM faculty member Dr. Chris Woods and Dr. Colin Duckett from Duke Health recently joined Congressman David Price on Facebook Live to help answer questions about COVID19.
Ryanne Wu, Geoff Ginsburg and Lori Orlando examined the differences in data detail and risk identification rates between FHH collection directly from individuals using paper-based forms and an interactive web-based platform.
CAGPM faculty and staff members validate a microarray-derived host response signature and explore performance in microbiology-negative and coinfection cases.
Geoff Ginsburg and team highlight breakthroughs in the development of enabling technologies that further the goal of personalized and precision medicine, and remaining challenges that, when addressed, may allow truly individualized patient care.
In a new review, Susanne Haga provides background on the use of PGx testing in children as well as mothers and discusses the challenges, benefits, and the ethical, legal and social implications of providing PGx testing to children.
Ricardo Henao was part of a team that developed a machine learning algorithm to evaluate thyroid fine-needle aspiration biopsy via whole slide images to predict malignancy.
Ryan Shaw co-authored a paper examining the use of mobile health technologies to generate and transmit data from diverse patients with type 2 diabetes mellitus in between clinic visits.
The laboratory brings together expertise in molecular microbiology with genome sciences to develop next-generation diagnostic tests.
We support biobanking activities including IRB, sample collection, processing, storage, bar-coded chain of custody and e-inventory management.